dc.contributor.author | Koech, DK | |
dc.contributor.author | Herman, JA | |
dc.contributor.author | Kofi-Tsekpo, MW | |
dc.contributor.author | Herman, SD. | |
dc.date.accessioned | 2013-06-11T09:53:34Z | |
dc.date.available | 2013-06-11T09:53:34Z | |
dc.date.issued | 1994 | |
dc.identifier.citation | Afr J Health Sci. 1994 Nov;1(4):147-150 | en |
dc.identifier.uri | http://hinari-gw.who.int/whalecomwww.ncbi.nlm.nih.gov/whalecom0/pubmed/12153338 | |
dc.identifier.uri | http://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/31462 | |
dc.description.abstract | Direct biological activity of a 1,2,4-trioxolane derivative was assessed in vitro using bacteria and fungi causing common infections. The product was found to be uniformly active against all organisms tested. In addition, it is active against certain tumour cells and protozoa and is also an immunomodulator. These observations are discussed in the light of the product's potential use in the clinical management of conditions in which its use is indicated. | en |
dc.language.iso | en | en |
dc.publisher | University of Nairobi, | en |
dc.title | Trioxolanes: A new generation of compounds with wide-ranging activities. | en |
dc.type | Article | en |
local.publisher | College of Health Sciences | en |